Investors Business DailyThu, 25 Jun 2026 14:04:58 GMTARS Pharma Collapses After CVS Punts Its Epinephrine Spray Decision To JanuarySPRY-24.57%
Seeking AlphaWed, 20 May 2026 09:27:24 GMTARS Pharmaceuticals: Still A Buy As Neffy Access ImprovesSPRY-24.57%
Seeking AlphaSat, 16 May 2026 01:30:42 GMTARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call TranscriptSPRY-24.57%
Zacks Investment ResearchFri, 15 May 2026 12:12:08 GMTARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue EstimatesSPRY-24.57%
BenzingaFri, 15 May 2026 06:08:33 GMTARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsSPRY-24.57%
Zacks Investment ResearchWed, 06 May 2026 15:01:16 GMTEarnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to DeclineSPRY-24.57%
Zacks Investment ResearchThu, 23 Apr 2026 13:45:46 GMTARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?SPRY-24.57%
